Stocks and Finance

Mylan

Mylan 5/11/2012

07:25 : Mylan (MYL) says it will launch sales of its generic version of Lipitor ... - Mylan (MYL) says it will launch sales of its generic version of Lipitor in France, Belgium, the U.K., the Netherlands and Ireland after winning regulatory approvals in each country. ...
Source : seekingalpha-com
06:59 : Mylan launches generic Lipitor in France, U.K. - NEW YORK (MarketWatch) -- Mylan Inc. said Friday it's launching sales of its generic version of the popular cardiovascular medicine Lipitor in France, Belgium, the U.K., the Netherlands and Ireland ...
Source : marketwatch-com

Mylan 5/10/2012

13:28 : Mylan ([[MYL]] +1.9%) gets a bump higher after the generic-drug maker ... - Mylan (MYL +1.9%) gets a bump higher after the generic-drug maker raised its FY12 earnings outlook earlier today. It now expects to earn between $2.45 - $2.55 per share. Street consensus is for an EPS of $2.42. The company also outlined plans ...
Source : seekingalpha-com

Mylan 4/30/2012

10:51 : Teva-Mylan deal to delay generic Nuvigil - Teva Pharmaceutical Industries Ltd. settled patent infringement litigation Monday with Mylan Inc. regarding Mylan’s efforts to sell a generic version of Nuvigil. Nuvigil is a treatment for excessive sleepiness associated with sleep apnea, ...
Source : bizjournals-com

Mylan 3/28/2012

08:38 : Mylan, Teva launch generic versions of Seroquel - Two drugmakers say they have started selling generic versions of the antipsychotic Seroquel, days after a U.S. court dismissed a bid by British pharmaceutical company AstraZeneca to extend the patent protecting its blockbuster drug....
Source : usnews-com

Mylan 3/15/2012

15:06 : Mylan drops out of Rottapharm talks: sources - (Reuters) - Generics drug maker Mylan has pulled out of talks to buy a stake in Italian pharmaceuticals firm Rottapharm, two people familiar with the situation said, posing another setback to the...
Source : reuters-com

Mylan 2/16/2012

15:06 : Forbes Earnings Preview: Mylan - Wall Street is optimistic about Mylan (MYL), which is slated to report its fourth quarter results on Tuesday, February 21, 2012. Analysts project a profit of 50 cents a share, a rise from 45 cents per share a year ago.
Source : forbes-com

Mylan 11/9/2011

09:29 : Mylan, Pfizer in dry-powder inhaler deal - Southpointe-based Mylan Inc. (Nasdaq: MYL) will manufacture and market a generic equivalent to Advair Diskus and Seretide Diskus dry-powder inhalers in an agreement with Pfizer (NYSE: PFE). The medications are used to treat asthma ...
Source : bizjournals-com

Mylan 10/24/2011

15:23 : Forbes Earnings Preview: Mylan Laboratories - Wall Street is high on Mylan Laboratories (MYL), expecting it to report earnings that are up 18.6% from a year ago when it reports its third quarter earnings on Wednesday, October 26, 2011. The consensus estimate is 51 cents ...
Source : forbes-com

Mylan 10/7/2011

22:12 : Mylan Inc. co-founder, WVU donor Puskar dies at 77 - MORGANTOWN, W.Va. (AP) -- Milan "Mike" Puskar, the co-founder and former chairman of generic drug maker Mylan Inc. and a philanthropist who gave tens of millions of dollars to West Virginia University, died Friday night at home after battling ...
Source : usnews-com

Mylan 6/3/2011

08:19 : Equity Research on Mylan Inc. and Watson Pharmaceuticals Inc. -- Generic ... - JOHANNESBURG, SOUTH AFRICA--(Marketwire - Jun 3, 2011) - www.stockcall.com/ offers investors comprehensive research on the Drugs - Generic industry and has completed analytical research on Mylan Inc. (NASDAQ: MYL) and Watson Pharmaceuticals|Watson ...
Source : marketwire-com
actualidad Mylan -

Mylan by date


Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Biotechnology

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts